| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |